Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
International Cancer Conference Journal|June 1, 2019
A case of premenopausal breast cancer with symptomatic cerebellar metastasis successfully treated by systemic endocrine therapy alone: relationship to biological featuresYoshitaka Fujiki, Yutaka Yamamoto, Mutsuko Yamamoto-Ibusuki, et al.Breast Cancer (Tokyo, Japan)|January 5, 2022
Predictive and prognostic significance of BRCAness in HER2-negative breast cancerAiko Sueta, Mutsuko Yamamoto-Ibusuki, Mai Tomiguchi, et al.Oncology Letters|October 21, 2021
Exosomal miRNA profiles of triple-negative breast cancer in neoadjuvant treatmentAiko Sueta, Yoshitaka Fujiki, Lisa Goto-Yamaguchi, et al.Breast Cancer Research and Treatment|August 29, 2018
Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profilingLisa Goto-Yamaguchi, Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, et al.Oncotarget|August 11, 2018
APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancerYoshitaka Fujiki, Yutaka Yamamoto, Aiko Sueta, et al.Breast Cancer (Tokyo, Japan)|September 13, 2012
High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein levelChunsen Xu, Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, et al.Cancer Science|January 24, 2016
Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancerMai Tomiguchi, Yutaka Yamamoto, Mutsuko Yamamoto-Ibusuki, et al.Clinical Breast Cancer|March 12, 2024
The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero SubtypesReiki Nishimura, Yoshitaka Fujiki, Tetsuhiko Taira, et al.Annals of Surgical Oncology|March 11, 2022
Satisfaction of Patients Who Received Breast-Conserving Surgery Using the Suture Scaffold Technique: A Single-Institution, Cross-Sectional StudyReiko Mitsueda, Anri Gen, Yoshitaka Fujiki, et al.Breast Cancer (Tokyo, Japan)|February 18, 2025
A novel formula to improve the accuracy and prognostic ability of determining the survival time after recurrent breast cancerReiki Nishimura, Yasuaki Sagara, Reiko Mitsueda, et al.Pageof 2